The science behind LEO Pharma Open Innovation
At LEO Pharma we help people achieve healthy skin by focusing on meeting the needs of individual people with skin diseases. We do this by better understanding their challenges and the healthcare environment in which they live. Our aim is to provide an expanded portfolio of treatments and other care solutions through internal innovation and external partnering.
We offer topical treatments for psoriasis, eczema, actinic keratosis, acne and skin infections, and we are expanding our dermatology offering to include biologics. We develop dermatology drugs, devices, delivery systems and digital health technologies.
LEO Pharma Open Innovation offers advanced cell-based and disease-like in vitro assays to evaluate a molecule’s ability to inhibit a disease state. Here you'll find more information about the assays we offer, so that you can explore your molecules' effects in these assays.
You can also send a question to the LEO Pharma Open Innovation team and we will get back to you as quickly as possible.
Psoriasis is a common, chronic, immune-mediated inflammatory disease that primarily involves the skin1. The negative impact of this condition on people’s lives can be immense. Psoriasis affects people of all ages, and in all countries. The reported prevalence of psoriasis in countries ranges from 0.09% to 11.43%1, making psoriasis a serious global problem affecting an estimated 125 million people worldwide2.
Atopic dermatitis (or 'eczema') is a chronic, inflammatory skin disorder resulting in redness, itching and oozing vesicular lesions that can become scaly or crusted. Over ten percent of all children are affected, and although the condition tends to clear up throughout childhood, it affects some people for life3.
1. World Health Organization. Global report on psoriasis. Available at: http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf [Accessed June 2017]
2. The International Federation of Psoriasis Associations. World Psoriasis Day. Available at: https://ifpa-pso.com/our-actions/world-psoriasis-day/ [Accessed July 2017]
3. Atopic dermatitis; Leung & Bieber; The Lancet; 2003. Available at: http://www.sciencedirect.com/science/article/pii/S0140673603121939?via%3Dihub [Accessed October 2017]